Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1984
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1984

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Deviations:
not applicable
GLP compliance:
yes
Type of assay:
micronucleus assay

Test material

Constituent 1
Reference substance name:
25485-88-5
EC Number:
607-733-0
IUPAC Name:
25485-88-5
Constituent 2
Reference substance name:
cyclohexyl salicylate
IUPAC Name:
cyclohexyl salicylate

Test animals

Species:
mouse
Strain:
CF-1
Sex:
male/female
Details on test animals or test system and environmental conditions:
Male mice were individually housed and females were housed 4/cage and given free access to rodent diet and drinking water except for 16 hours prior and 3 hours post dosing of the high-dose group and 4-6 prior to 3 hours post dosing of the other test groups. The animal room had a light photoperiod of 12 hours.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
Peanut Oil
Details on exposure:
8-week-old CFW-1 (Winkelmann) albino mice (7/sex/group) weighing 20-30 g were gavaged with 3000 mg test substance/kg body weight in peanut oil at a dose volume of 10 ml/kg body weight and euthanized at 24, 48, or 72 hours post dosing.
Duration of treatment / exposure:
dose volume of 10 ml/kg body weight and euthanized at 24, 48, or 72 hours post dosing.
Frequency of treatment:
Once
Post exposure period:
24, 48, or 72 hours
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
300 mg/kg
Basis:
nominal conc.
Remarks:
Doses / Concentrations:
1500 mg/kg
Basis:
nominal conc.
Remarks:
Doses / Concentrations:
3000 mg/kg
Basis:
nominal conc.
No. of animals per sex per dose:
7/sex/group
Positive control(s):
Positive control (20 mg/kg body weight of Endoxan)

Examinations

Tissues and cell types examined:
Bone marrow
Details of tissue and slide preparation:
The smears were fixed in methanol, rinsed with distilled water 2x, stained in 10% Giemsa, rinsed with distilled water, and air-dried. The stained smears were examined by light microscopy to determine the incidence of micronucleated cells per 1000 polychromatic erythrocytes.
Evaluation criteria:
The proportion of polychromatic to normochromatic erythrocytes was assessed by examination of at least 1000 erythrocytes and the number of micronucleated normochromatic erythrocytes was recorded.
Statistics:
Statistical analyses were conducted using the tables of Kastenbaum and Bowman.

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Vehicle controls validity:
valid

Any other information on results incl. tables

Dose: 300 mg/kg-Effects:no effects. Results:No mortalities; no statistically significant change in number of micronucleated polychromatic erythrocytes or micronucleated normochromatic erythrocytes; no statistically significant change in the ratio of polychromatic to normochromatic erythrocytes compared to vehicle control.
Dose: 1500 mg/kg-Effects:no effects. Results:No mortalities; no statistically significant change in number of micronucleated polychromatic erythrocytes or micronucleated normochromatic erythrocytes; no statistically significant change in the ratio of polychromatic to normochromatic erythrocytes compared to vehicle control.
Dose: 3000 mg/kg-Effects:no effects. Results:No mortalities; no statistically significant change in number of micronucleated polychromatic erythrocytes or micronucleated normochromatic erythrocytes at any of the 3 sampling times; no statistically significant change in the ratio of polychromatic to normochromatic erythrocytes compared to vehicle control.

Applicant's summary and conclusion

Conclusions:
Under the conditions of this study, the test substance did not show any evidence of mutagenic potential when administered orally.
Executive summary:
Under the conditions of this study, the test substance did not show any evidence of mutagenic potential when administered orally.